Xin Lang Cai Jing·2025-10-10 01:29Core Viewpoint - Spring Medical experienced a decline of 3.93% in stock price on October 9, with a trading volume of 93.15 million yuan, indicating potential market volatility and investor sentiment concerns [1] Financing Summary - On October 9, Spring Medical had a financing buy-in amount of 14.07 million yuan and a financing repayment of 8.81 million yuan, resulting in a net financing buy-in of 5.26 million yuan [1] - As of October 9, the total financing and securities lending balance for Spring Medical was 38.03 million yuan, with the financing balance accounting for 0.55% of the circulating market value, indicating a high level compared to the past year [1] - The financing balance of 38.02 million yuan exceeds the 80th percentile level over the past year, suggesting strong investor interest [1] Securities Lending Summary - On October 9, there were no shares repaid or sold in securities lending, with a remaining quantity of 200 shares and a securities lending balance of 4,786 yuan, which is above the 70th percentile level over the past year [1] Company Overview - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, specializes in the research, production, and sales of implantable orthopedic medical devices, including joint prosthetics and spinal implants [2] - The company's main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems, with exports to various regions including Asia, South America, Africa, Oceania, and Europe [2] - As of June 30, the company reported a revenue of 488 million yuan for the first half of 2025, representing a year-on-year growth of 28.27%, and a net profit attributable to shareholders of 114 million yuan, up 44.85% year-on-year [2] Dividend Summary - Since its A-share listing, Spring Medical has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [3] Institutional Holdings Summary - As of June 30, 2025, the top ten circulating shareholders included Ping An Low Carbon Economy Mixed A, which increased its holdings by 2.77 million shares to 3.77 million shares, and Southern Medical Health Flexible Allocation Mixed A, which entered the top ten with 1.60 million shares [3] - Notably, Zhonggeng Small Cap Value Stock and Hong Kong Central Clearing Limited exited the top ten circulating shareholders list [3]